What is the recommended treatment for anetoderma?

Treatment for Anetoderma

There is no established effective treatment for anetoderma, but when secondary causes are identified—particularly Borrelia burgdorferi (Lyme disease) or syphilis—treating the underlying infection with appropriate antibiotics may prevent disease progression.

Key Clinical Approach

1. Identify and Treat Secondary Causes

The most critical step is determining whether anetoderma is primary (idiopathic) or secondary to an underlying condition:

Screen for infectious causes:

• Borrelia burgdorferi (Lyme disease): Check serum IgG/IgM titers with confirmatory Western blot. If positive, perform PCR on lesional skin biopsy 1

  • Treatment: Doxycycline 100 mg twice daily for 30 days has shown efficacy in stopping progression and preventing new lesions 1, 2
  • One case demonstrated significant decrease in anti-Borrelia titers and cessation of new lesions after treatment 1

• Syphilis: Obtain RPR/VDRL and confirmatory treponemal testing

  • Treatment: Benzathine penicillin per standard syphilis protocols 3, 4, 5
  • Note: Anetoderma may paradoxically develop after penicillin treatment for secondary syphilis, particularly in HIV patients 4

Screen for autoimmune conditions: Antiphospholipid antibodies, lupus anticoagulant, and other relevant autoimmune markers based on clinical presentation

2. Treatment Options for Established Lesions

When no treatable underlying cause is identified or lesions persist after treating secondary causes:

Combination laser therapy (highest quality evidence for cosmetic improvement):

• 595-nm pulsed dye laser (PDL) + 1550-nm non-ablative fractionated laser (NAFL) 6
  • Protocol: 3 treatments spaced 3 weeks apart
  • Demonstrated histologic increase in dermal elastin fibers and decreased elastin fragmentation
  • Improved lesion color, texture, and overall appearance
  • This represents the only treatment modality with documented histologic improvement of elastic fiber content

3. What Does NOT Work

Current evidence shows no effective treatment for reversing established primary anetoderma lesions 3, 4. Most reported interventions have been unsuccessful.

Critical Pitfalls to Avoid

1. Missing treatable infections: Always screen for Borrelia and syphilis before labeling as "primary" anetoderma. Early antibiotic treatment can prevent disfiguring progression 1

2. Inadequate workup: Histologic confirmation is mandatory to differentiate from other elastolysis conditions (cutis laxa, mid-dermal elastolysis) 4

3. Timing of biopsy: Perform PCR on lesional skin, not just serology, as this may be the only way to confirm Borrelia-induced cases 1

Clinical Algorithm

1. Confirm diagnosis: Skin biopsy with Verhoeff-Van Gieson stain showing loss of dermal elastic fibers
2. Infectious workup: Borrelia serology + PCR from lesional skin; syphilis serology
3. If infection identified: Treat with appropriate antibiotics (doxycycline for Borrelia, penicillin for syphilis)
4. If primary/idiopathic: Consider combination PDL + NAFL for cosmetic improvement 6
5. Monitor: Follow for development of new lesions; if progression stops after antibiotics, confirms infectious etiology

The prognosis for reversing established lesions remains poor, making early identification and treatment of secondary causes the most impactful intervention.